Skip to content
★ Sign in to follow
AP

AFT Pharmaceuticals Limited Stock: price and insider trades · New Zealand

NZ·Mcap NZ$481.4MHealth Care

No insider purchase over the last 90 days. The latest, by AFT Insider, was filed 01 Sept 2025.

AFT Pharmaceuticals Limited: what insiders have been doing

AFT Pharmaceuticals Limited belongs to the Health Care sector. Filings by its managers are published through NZX. The past year has been quiet: not a single insider filing for AFT Pharmaceuticals Limited. The previous disclosure was published on 1 September 2025.

Our records for AFT Pharmaceuticals Limited go back to 2018, with 21 purchases and no sales on the open market in total.

Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. Source: insider filings from NZX. Past trades are no guide to future returns.

Insider Decl.
37
Thresholds
n/a
Buy Volume
€423,756
21 ops. · all time
Sell Volume
n/a
n/a

Who traded when

BuySale
AFT Insider3 buys

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 15,415 of 26,912 companies
47.2
score / 100
Value
33
Quality
61
FCF yld-4.0%
Earn yld3.1%
EV/EBITDA19.3x
ROE14%
Gross mgn43%
Net mgn5.9%
Debt/EBITDA1.9x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

NZ$4.59
Analyst consensus
2 analysts
·
NZ$4.65Target NZ$4.85(+6%)NZ$5.05
Income statement
RevenueNZ$251.2M
Gross profitNZ$107M43% margin
EBITDANZ$27.8M11% margin
Net incomeNZ$14.7M5.8% margin
Valuation
PER (trailing)32.8x
PER (forward)19.4x
P/Book4.4x
Beta0.47
Balance sheet & cash
Market capNZ$481.4M
Total debtNZ$54.1M
Free Cash Flow-NZ$19.3M
Debt / Equity50%
Profitability & ownership
ROE13.7%
ROA7.9%
% insiders77.6%
% institutions1.2%
Last declaration on 1 September 2025
Declarations37 total
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    DirectorExecutives
    126 NZD11NZX
    45 shares@ NZ$2.79990.0% of flowOrdinary ShareNZX Main BoardNZX:443010
    Canonical exit: 25 Feb 2025 (T+90)
  • ▲
    DirectorExecutives
    28,112 NZD11NZX
    10,087 shares@ NZ$2.7873.7% of flowOrdinary ShareNZX Main BoardNZX:442744
    Canonical exit: 23 Feb 2025 (T+90)
  • ▲
    DirectorExecutives
    257,498 NZD14NZX
    95,000 shares@ NZ$2.710534.0% of flowOrdinary ShareNZX Main BoardNZX:442743
    Canonical exit: 20 Feb 2025 (T+90)
  • ●
    Related company / holdingExecutives
    0NZX
    Ordinary ShareNZX Main BoardNZX:441478
  • ●
    Related company / holdingExecutives
    0NZX
    Ordinary ShareNZX Main BoardNZX:431145
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    DirectorExecutives
    170,814 NZD0NZX
    40,670 shares@ NZ$4.20Ordinary ShareNZX Main BoardNZX:385177
    Canonical exit: 17 Mar 2022 (T+90)
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    Executives
    Executives
    0NZX
  • ●
    Executives
    Executives
    0NZX
  • ●
    Related company / holdingExecutives
    0NZX
    Ordinary ShareNZX Main BoardNZX:360142
  • Ordinary ShareNZX Main BoardNZX:359863
  • ●
    Executives
    Executives
    0NZX
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    DirectorExecutives
    99,998 NZD0NZX
    26,666 shares@ NZ$3.75Ordinary ShareNZX Main BoardNZX:355715
    Canonical exit: 30 Sept 2020 (T+90)
  • ▲
    Executives
    Executives
    0NZX
  • ▲
    DirectorExecutives
    46,604 NZD0NZX
    12,105 shares@ NZ$3.85Ordinary ShareNZX Main BoardNZX:355337
    Canonical exit: 23 Sept 2020 (T+90)
  • ▲
    DirectorExecutives
    77,330 NZD0NZX
    20,000 shares@ NZ$3.8665Ordinary ShareNZX Main BoardNZX:354820
    Canonical exit: 13 Sept 2020 (T+90)

25 of 37 declarations

About AFT Pharmaceuticals Limited

AFT is a company listed on the XNZE market, specializing in the financial sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations